For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...

Eli Lilly on Thursday expanded its direct-to-consumer online platform LillyDirect to include telehealth providers to diagnose ...

Research shows experimental anti-amyloid drug reduced cognitive symptom risk by 50% in people with rare genetic mutations ...

Eli Lilly is expanding its menu of direct-to-consumer healthcare offerings. | Eli Lilly is expanding its menu of ...

A new study has found that a compound that’s often used in hair loss products has a promising effect on reversing Alzheimer’s ...

"We're trying to prolong the stage where patients still have some independence," the company's chief medical officer said.

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

Eli Lilly is expanding care offerings on its direct-to-consumer (DTC) platform LillyDirect, now offering connections to ...

New research identifies 16 genes linked to Alzheimer's risk while experts emphasize powerful lifestyle changes that could ...

The probiotic-rich drink kefir may be a potential complementary treatment for Alzheimer’s disease by helping improve ...

But a new study looking at the anti-amyloid drug gantenerumab could change all that. Published in the Lancet Neurology ...